About
Corporate Overview
Founder
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Contact
CEO Updates
Articles & Discussions
Video News
Hiring
Videos
News
CEO Updates
Patient Testimonials
Publications
Technology Overview
Manufacturing
Intellectual Property
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
Platform
Critical Limb Ischemia
News & Media
News / Press Releases
Blog
Investor
Investor Presentation
Overview
Public Filings
AGM Materials
Investor enquiry
MENU ≡
About
Corporate Overview
Founder
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Contact
CEO Updates
Articles & Discussions
Video News
Hiring
Videos
News
CEO Updates
Patient Testimonials
Publications
Technology Overview
Manufacturing
Intellectual Property
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
Platform
Critical Limb Ischemia
News & Media
News / Press Releases
Blog
Investor
Investor Presentation
Overview
Public Filings
AGM Materials
Investor enquiry
News & Media
all
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Nov 26
/ 2014
Hemostemix and Technical Ventures Complete RTO Transaction
Oct 02
/ 2014
Theravitae Inc. Announces Leadership Transition
Jun 25
/ 2014
Hemostemix Advances Clinical Trial Preparation
May 05
/ 2014
Hemostemix Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
Apr 22
/ 2014
Hemostemix Announces its Second US Patent
